Predict your next investment

SOFTWARE (NON-INTERNET/MOBILE) | Healthcare Software
biosignia.com

See what CB Insights has to offer

Stage

Acquired | Acquired

Total Raised

$320K

About BioSignia

BioSignia provides risk assessment solutions to the life and health insurance industries, as well as to corporations, practitioners, and organizations concerned with proactive health promotion and wellness. BioSignia's flagship technology, Synthesis Analysis, is a statistical method for summarizing the epidemiological association of the underlying contributing factors of multifactor diseases from the disparate medical literature into comprehensive prediction models. This method is capable of summarizing virtually the entire body of evidence on epidemiological factors correlated with the onset of slowly developing multifactor diseases such as cardiovascular disease, diabetes, cancer, arthritis, and other serious chronic illnesses.

BioSignia Headquarter Location

1822 East NC Highway 54 Suite 350

Durham, North Carolina, 27713,

United States

919-933-2021

Latest BioSignia News

BioSignia's Ashlee Duncan is Two-Faced - Press Releases

Jun 21, 2012

RESEARCH TRIANGLE PARK, N.C., June 20, 2012 /PRNewswire/ -- Ashlee Duncan, PhD, BioSignia's senior vice president, product development and science, doesn't like to be bored, enjoys multiple challenges, and was known for getting the job done at her former place of employment, the Drug Development Sciences division of GlaxoSmithKline. But ask her coworkers at BioSignia and they will outright tell you Ashlee is two-faced and they like it. "Her science disciplines, a master's in

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioSignia

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioSignia is included in 4 Expert Collections, including Diabetes.

D

Diabetes

1,750 items

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

H

Health Plans & Benefits Management

694 items

Companies developing or offering digital platforms and services, including online insurance marketplaces, data analytics for claims adjustment, benefits administration, and payments systems, that help make private health insurance more affordable, navigable, or transparent.

D

Digital Health

11,245 items

Companies leveraging digital technology for healthcare, consumer health, clinical research, and life science (e.g. biopharma, medtech) applications.

BioSignia Patents

BioSignia has filed 2 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/18/2014

Medical scoring system, Heart diseases, Intensive care medicine, Epidemiology, Syndromes

Application

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/18/2014

00/00/0000

Grant Date

00/00/0000

Title

Subscribe to see more

Related Topics

Medical scoring system, Heart diseases, Intensive care medicine, Epidemiology, Syndromes

Subscribe to see more

Status

Application

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.